How does Trendshare evaluate SAGE as a worked example?

This example shows how we apply the Trendshare checklist to SAGE: earnings power, cash generation, valuation, and margin of safety. We look at business quality, free cash flow trends, price to earnings, and whether there is a reasonable margin of safety at the current price of 40.35.

Sage Therapeutics Stock Price and Value Analysis

Should you buy Sage Therapeutics stock? (NasdaqGM:SAGE). Let's see how it does in our automated value investing analysis system.

Key Facts

Ticker: SAGE (NasdaqGM)
Sector: Healthcare
Industry: Biotechnology

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Sage Therapeutics to reach your target.

Target type Target price Target total return %

Current price

Expected annual return (compound annual growth rate, CAGR)

Margin of safety (%)

Target price (Trendshare FV)

Include dividend yield
N/A

Advantages	Disadvantages	Neutral
None.	This company has wild ups and downs. This company is not making money. This company is less known than others. This stock looks overpriced.	This company pays no dividend.

Inside the SAGE Numbers

	SAGE Price (Sage Therapeutics stock price per share)	$40.35
× PE Ratio Versus Sector The PE ratio measures the reported earnings of a company to its current stock price. While earnings are easy to manipulate on the balance sheet, this ratio gives you a sense of what buyers are willing to pay for the stock—what they believe it will do in the future. Comparing a stock's PE to the average PE of companies in its industry gives you a sense of market sentiment about the stock and how well it fares financially. It's not the only number, nor the most important, but comparing similar companies is valuable. A ratio far above or below that of its peers is significant. Industries are more specific than sectors, so companies within most industries are more similar than are companies within an industry. Be aware that the size and customers of companies are important to their prospects. Close ^[?]	PE Ratio versus Sector	82% lower than other Healthcare stocks
× PE Ratio Versus Industry The PE ratio measures the reported earnings of a company to its current stock price. While earnings are easy to manipulate on the balance sheet, this ratio gives you a sense of what buyers are willing to pay for the stock—what they believe it will do in the future. Comparing a stock's PE to the average PE of companies in its sector gives you a sense of market sentiment about the stock and how well it fares financially. It's not the only number, nor the most important, but comparing similar companies is valuable. A ratio far above or below that of its peers is significant. Be aware that sectors are very broad, with many types of companies in the same sector. Close ^[?]	PE Ratio versus Industry	93% lower than other Biotechnology stocks
× Free Cash Flow Jitter The free cash flow jitter of a stock measures how much the company's free cash flow varies from its historical trend, on average. While it's always nice to make more money than you expected, a company with predictable free cash flow is stable and good. A company with wild swings in its free cash flow warrants further research. In general, the lower this number, the better. Close ^[?]	Free Cash Flow Jitter	584%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 3,607,644 shares shorted. With 51,964,245 shares available for purchase and an average trading volume over the past 10 trading days of 614,150, it would take at least 5.874 days for all of the short holders to cover their shorts.

Estimate Intrinsic Value (DCF)

Project future free cash flow and discount it back to today to compare market price vs intrinsic value. See how compound returns work over time.

📊 Intrinsic Value Calculator (DCF Method)

Calculate the present value of future cash flows to determine stock intrinsic value.

Annual Free Cash Flow ($):

Current or most recent year free cash flow (operating cash - capex)

Expected Annual Growth Rate (%):

Conservative estimate (3-7% for mature companies, 10-20% for growth)

Discount Rate (%):

Required rate of return (8-10% stable, 12-15% growth, 15%+ speculative)

Projection Period (Years):

Longer projections are less certain but may reveal more value

Terminal Value Multiple:

Exit multiple for terminal value (10-15x typical for mature companies)

Calculation Results

Total Intrinsic Value:

Discounted Cash Flows:

Terminal Value (PV):

Year	Future CF	Present Value

How to use this result: Compare the intrinsic value to the current stock price. If intrinsic value is significantly higher than market price (30-50% margin of safety), the stock may be undervalued. Remember, these are estimates based on your assumptions.

Should You Buy SAGE?

Learn how to evaluate stocks, understand expected returns, and build a value investing strategy.

See How Returns Compound →

Continue Learning: Value Investing Guides

What is a Good Annual Rate of Return?

Understand how to evaluate investment returns, discount rates, and what realistic expectations look like for long-term value investing.

Should Value Investors Pursue High-Yield Stocks?

Learn when dividend yields signal opportunity versus risk, and how to evaluate dividend sustainability in your portfolio.

How to Estimate Growth or Forecast Earnings

Master the methods for projecting company growth rates and earnings, essential for calculating intrinsic value with confidence.

Is Sage Therapeutics Stock on Sale?

Based on our analysis, we believe that you should not buy Sage Therapeutics right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Advertisement supports free stock analysis content.

Should You Buy SAGE Stock?

Does Sage Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Step 1 — Snapshot
- Price: 40.35
- Market cap: $2.4B
- EPS: 11.43
Step 2 — Valuation checks
- P/E: 3.53
- FCF yield: —
- Date checked: Dec 26, 2025
Step 3 — Margin of safety
- Compare price to fair value and safety price.
- Look for durable cash generation and reasonable leverage.
- Decide if it passes your personal checklist.

Illustrative sparkline of recent price-like movements (not an actual price series). The blue line shows a simplified trend; the gray baseline is a notional recent level. This graphic is a visual aid only — use the numeric values in the steps above for decisions.